# Luca Bianchi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/luca-bianchi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,721 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 50 |
| i10-index | 306 |
| Last Known Institution | University of Rome Tor Vergata |
| OpenAlex ID | https://openalex.org/A5004401304 |
| ORCID iD | 0000-0001-8697-6896 |
| Works | 693 |

## Researcher papers

- [Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study](https://scholariq.org/papers/conversion-from-clinically-isolated-syndrome-to-multiple-sclerosis-a-large/)
- [Effects of novelty and habituation on acetylcholine, GABA, and glutamate release from the frontal cortex and hippocampus of freely moving rats](https://scholariq.org/papers/effects-of-novelty-and-habituation-on-acetylcholine-gaba-and-glutamate-release/)
- [Potential of Curcumin in Skin Disorders](https://scholariq.org/papers/potential-of-curcumin-in-skin-disorders/)
- [Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial](https://scholariq.org/papers/adjuvant-vemurafenib-in-resected-brafv600-mutation-positive-melanoma-brim8-a/)
- [The Predictive Value of the EWGSOP Definition of Sarcopenia: Results From the InCHIANTI Study](https://scholariq.org/papers/the-predictive-value-of-the-ewgsop-definition-of-sarcopenia-results-from-the/)
- [Italian guidelines on the systemic treatments of moderate‐to‐severe plaque psoriasis](https://scholariq.org/papers/italian-guidelines-on-the-systemic-treatments-of-moderate-to-severe-plaque/)
- [Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study*](https://scholariq.org/papers/evidence-for-a-window-of-opportunity-in-hidradenitis-suppurativa-treated-with/)
- [CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis](https://scholariq.org/papers/cxcl4-assembles-dna-into-liquid-crystalline-complexes-to-amplify-tlr9-mediated/)
- [NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study](https://scholariq.org/papers/nmda-receptor-antagonists-decrease-gaba-outflow-from-the-septum-and-increase/)
- [Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics](https://scholariq.org/papers/adalimumab-for-severe-psoriasis-and-psoriatic-arthritis-an-open-label-study-in/)
- [Burden of Disease in Real-Life Setting of Patients With Atopic Dermatitis: Italian Data From the MEASURE-AD Study](https://scholariq.org/papers/burden-of-disease-in-real-life-setting-of-patients-with-atopic-dermatitis/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [University of Rome Tor Vergata](https://scholariq.org/institutions/university-of-rome-tor-vergata/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
